Skip to main content
Top
Published in: Journal of Nuclear Cardiology 5/2017

Open Access 01-10-2017 | Original Article

Correction of collimator-dependent differences in the heart-to-mediastinum ratio in 123I-metaiodobenzylguanidine cardiac sympathetic imaging: Determination of conversion equations using point-source imaging

Authors: Yusuke Inoue, MD, PhD, Yutaka Abe, RT, Kei Kikuchi, RT, Keiji Matsunaga, MD, Ray Masuda, MD, PhD, Kazutoshi Nishiyama, MD, PhD

Published in: Journal of Nuclear Cardiology | Issue 5/2017

Login to get access

Abstract

Background

Septal penetration causes collimator-dependent differences in the heart-to-mediastinum (H/M) ratio in 123I-metaiodobenzylguanidine (MIBG) cardiac imaging. We investigated generally applicable methods to correct such differences.

Methods and Results

Four hours after 123I-MIBG injection, 40 patients underwent anterior chest imaging successively with medium-energy (ME) and various non-ME collimators. The H/M ratios obtained with the non-ME collimators before and after 123I-dual-window penetration correction were compared with the ME-derived standard values to determine patient-based conversion equations for empiric and combined corrections, respectively. A 123I point source was imaged with various collimators, and the central ratio, the ratio of count in a small central region of interest to count in a large one, was calculated. The method of predicting the conversion equations from the central ratios was determined. Correction using the patient-based conversion equations removed systematic underestimation of the H/M ratios obtained with the non-ME collimators, and combined correction depressed residual random errors to some degree. Point-source-based equations yielded results comparable to the patient-based equations.

Conclusions

Empiric and combined corrections effectively reduce collimator-dependent differences in the H/M ratio. The conversion equations can be predicted from simple point-source imaging, which would allow to apply these corrections to data obtained with various collimators.
Appendix
Available only for authorised users
Literature
1.
go back to reference Nakata T, Nakajima K, Yamashina S, Yamada T, Momose M, Kasama S, et al. A pooled analysis of multicenter cohort studies of 123I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure. JACC Cardiovasc Imaging 2013;6:772-84.CrossRefPubMed Nakata T, Nakajima K, Yamashina S, Yamada T, Momose M, Kasama S, et al. A pooled analysis of multicenter cohort studies of 123I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure. JACC Cardiovasc Imaging 2013;6:772-84.CrossRefPubMed
2.
3.
go back to reference Inoue Y. 123I-MIBG cardiac imaging: Acquisition protocols and correction methods for quantitative evaluation. Curr Cardiovasc Imaging Rep 2015;8:9306.CrossRef Inoue Y. 123I-MIBG cardiac imaging: Acquisition protocols and correction methods for quantitative evaluation. Curr Cardiovasc Imaging Rep 2015;8:9306.CrossRef
4.
go back to reference Inoue Y, Suzuki A, Shirouzu I, Machida T, Yoshizawa Y, Akita F, et al. Effect of collimator choice on quantitative assessment of cardiac iodine 123 MIBG uptake. J Nucl Cardiol 2003;10:623-32.CrossRefPubMed Inoue Y, Suzuki A, Shirouzu I, Machida T, Yoshizawa Y, Akita F, et al. Effect of collimator choice on quantitative assessment of cardiac iodine 123 MIBG uptake. J Nucl Cardiol 2003;10:623-32.CrossRefPubMed
5.
go back to reference Verberne HJ, Feenstra C, de Jong WM, Somsen GA, van Eck-Smit BL, Busemann Sokole E. Influence of collimator choice and simulated clinical conditions on 123I-MIBG heart/mediastinum ratios: A phantom study. Eur J Nucl Med Mol Imaging 2005;32:1100-7.CrossRefPubMed Verberne HJ, Feenstra C, de Jong WM, Somsen GA, van Eck-Smit BL, Busemann Sokole E. Influence of collimator choice and simulated clinical conditions on 123I-MIBG heart/mediastinum ratios: A phantom study. Eur J Nucl Med Mol Imaging 2005;32:1100-7.CrossRefPubMed
6.
go back to reference Flotats A, Carrió I, Agostini D, Le Guludec D, Marcassa C, Schäfers M, et al. Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging 2010;37:1802-12.CrossRefPubMed Flotats A, Carrió I, Agostini D, Le Guludec D, Marcassa C, Schäfers M, et al. Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging 2010;37:1802-12.CrossRefPubMed
7.
go back to reference Inoue Y, Abe Y, Itoh Y, Asano Y, Kikuchi K, Sakamoto Y, et al. Acquisition protocols and correction methods for estimation of the heart-to-mediastinum ratio in 123I-metaiodobenzylguanidine cardiac sympathetic imaging. J Nucl Med 2013;54:707-13.CrossRefPubMed Inoue Y, Abe Y, Itoh Y, Asano Y, Kikuchi K, Sakamoto Y, et al. Acquisition protocols and correction methods for estimation of the heart-to-mediastinum ratio in 123I-metaiodobenzylguanidine cardiac sympathetic imaging. J Nucl Med 2013;54:707-13.CrossRefPubMed
8.
go back to reference Inoue Y, Abe Y, Asano Y, Asano Y, Kikuchi K, Sakamoto Y, et al. An improved method for estimating the heart-to-mediastinum ratio from cardiac sympathetic nerve imaging with low-energy high-resolution collimators. J Nucl Cardiol 2014;21:614-21.CrossRefPubMed Inoue Y, Abe Y, Asano Y, Asano Y, Kikuchi K, Sakamoto Y, et al. An improved method for estimating the heart-to-mediastinum ratio from cardiac sympathetic nerve imaging with low-energy high-resolution collimators. J Nucl Cardiol 2014;21:614-21.CrossRefPubMed
9.
go back to reference Verschure DO, de Wit TC, Bongers V, Hagen PJ, Sonneck-Koenne C, D’Aron J, et al. 123I-MIBG heart-to-mediastinum ratio is influenced by high-energy photon penetration of collimator septa from liver and lung activity. Nucl Med Commun 2015;36:279-85.CrossRefPubMed Verschure DO, de Wit TC, Bongers V, Hagen PJ, Sonneck-Koenne C, D’Aron J, et al. 123I-MIBG heart-to-mediastinum ratio is influenced by high-energy photon penetration of collimator septa from liver and lung activity. Nucl Med Commun 2015;36:279-85.CrossRefPubMed
10.
go back to reference Nakajima K, Matsubara K, Ishikawa T, Motomura N, Maeda R, Akhter N, et al. Correction of iodine-123-labeled meta-iodobenzylguanidine uptake with multi-window methods for standardization of the heart-to-mediastinum ratio. J Nucl Cardiol 2007;14:843-51.CrossRefPubMed Nakajima K, Matsubara K, Ishikawa T, Motomura N, Maeda R, Akhter N, et al. Correction of iodine-123-labeled meta-iodobenzylguanidine uptake with multi-window methods for standardization of the heart-to-mediastinum ratio. J Nucl Cardiol 2007;14:843-51.CrossRefPubMed
11.
go back to reference Nakajima K, Okuda K, Matsuo S, Yoshita M, Taki J, Yamada M, et al. Standardization of metaiodobenzylguanidine heart to mediastinum ratio using a calibration phantom: Effects of correction on normal databases and a multicentre study. Eur J Nucl Med Mol Imaging 2012;39:113-9.CrossRefPubMed Nakajima K, Okuda K, Matsuo S, Yoshita M, Taki J, Yamada M, et al. Standardization of metaiodobenzylguanidine heart to mediastinum ratio using a calibration phantom: Effects of correction on normal databases and a multicentre study. Eur J Nucl Med Mol Imaging 2012;39:113-9.CrossRefPubMed
12.
go back to reference Nakajima K, Okuda K, Yoshimura M, Matsuo S, Wakabayashi H, Imanishi Y, et al. Multicenter cross-calibration of I-123 metaiodobenzylguanidine heart-to-mediastinum ratios to overcome camera-collimator variations. J Nucl Cardiol 2014;21:970-8.CrossRefPubMedPubMedCentral Nakajima K, Okuda K, Yoshimura M, Matsuo S, Wakabayashi H, Imanishi Y, et al. Multicenter cross-calibration of I-123 metaiodobenzylguanidine heart-to-mediastinum ratios to overcome camera-collimator variations. J Nucl Cardiol 2014;21:970-8.CrossRefPubMedPubMedCentral
13.
go back to reference Jacobson AF, Centofanti R, Babalola OI, Dean B. Survey of the performance of commercial dose calibrators for measurement of 123I activity. J Nucl Med Technol 2011;39:302-6.CrossRefPubMed Jacobson AF, Centofanti R, Babalola OI, Dean B. Survey of the performance of commercial dose calibrators for measurement of 123I activity. J Nucl Med Technol 2011;39:302-6.CrossRefPubMed
14.
go back to reference Inoue Y, Shirouzu I, Machida T, Yoshizawa Y, Akita F, Doi I, et al. Physical characteristics of low and medium energy collimators for 123I imaging and simultaneous dual-isotope imaging. Nucl Med Commun 2003;24:1195-202.CrossRefPubMed Inoue Y, Shirouzu I, Machida T, Yoshizawa Y, Akita F, Doi I, et al. Physical characteristics of low and medium energy collimators for 123I imaging and simultaneous dual-isotope imaging. Nucl Med Commun 2003;24:1195-202.CrossRefPubMed
15.
go back to reference Inoue Y, Shirouzu I, Machida T, Yoshizawa Y, Akita F, Minami M, et al. Collimator choice in cardiac SPECT with I-123-labeled tracers. J Nucl Cardiol 2004;11:433-9.CrossRefPubMed Inoue Y, Shirouzu I, Machida T, Yoshizawa Y, Akita F, Minami M, et al. Collimator choice in cardiac SPECT with I-123-labeled tracers. J Nucl Cardiol 2004;11:433-9.CrossRefPubMed
Metadata
Title
Correction of collimator-dependent differences in the heart-to-mediastinum ratio in 123I-metaiodobenzylguanidine cardiac sympathetic imaging: Determination of conversion equations using point-source imaging
Authors
Yusuke Inoue, MD, PhD
Yutaka Abe, RT
Kei Kikuchi, RT
Keiji Matsunaga, MD
Ray Masuda, MD, PhD
Kazutoshi Nishiyama, MD, PhD
Publication date
01-10-2017
Publisher
Springer US
Published in
Journal of Nuclear Cardiology / Issue 5/2017
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-016-0546-8

Other articles of this Issue 5/2017

Journal of Nuclear Cardiology 5/2017 Go to the issue